Axogen, Inc.

AXGN is the ticker symbol for Axogen, Inc., a publicly traded US company.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Key metrics include a return on equity of -8.0%, a debt-to-equity ratio of 0.18.

The company reports trailing twelve-month revenue of $61.46M and net loss of $19.58M.

FINOTAUR aggregates real-time and fundamental data on AXGN to help traders and investors make informed decisions. Track AXGN in your trading journal alongside other positions for a unified view of your portfolio.